The Psychedelic That’s Changing Lives: Addiction, Anxiety, Depression, Neurodegenerative Diseases & More
What if one psychedelic plant could change how we approach trauma, addiction, and even neurodegenerative diseases? In this eye-opening episode of Keeping It Real, Jillian sits down with Bryan Hubbard, a leading voice in the psychedelic therapy space, to explore the power of Ibogaine therapy. Together, they take a deep dive into:How ibogaine works in the brain to disrupt addiction cycles, rewire trauma pathways, and stimulate neuroplasticity to help people with everything from sobriety to weight loss. The powerful potential of ibogaine therapy to address depression, anxiety, PTSD, and stress-related illnessWhy ibogaine may offer hope for those experiencing cognitive decline, and how it's being studied for conditions like Parkinson’s disease, multiple sclerosis (MS), and Lyme diseaseThe recent Stanford University–Ambio study, published in Nature Medicine, showing remarkable improvements in veterans with traumatic brain injuries — and no serious adverse eventsWhy veterans, trauma survivors, and chronic illness patients are turning to alternative, plant-based healing modalities While ibogaine therapy remains unapproved by the FDA and is only legal in certain countries, this episode brings awareness to a growing global movement pushing the boundaries of how we understand and treat human suffering. Disclaimer: This episode is for educational and informational purposes only. Ibogaine is not FDA-approved and should not be considered medical advice. Always consult with a qualified healthcare provider.
March 28, 2025
1 hr 34 min
833
Full
815 of 931

Episode 833 · March 28, 2025
The Psychedelic That’s Changing Lives: Addiction, Anxiety, Depression, Neurodegenerative Diseases & More
0:00 / 1:34:47
Excerpt playback isn’t available for this episode — use the full-episode link.
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
Jillian Michaels Episodes Around March 28, 2025
Episode 815 of 931 — walk the feed in the order it was published.
1:14:34The Untold Motives of Luigi Mangione and the Dark Side of Healthcare Power
1:34:47This episodeThe Psychedelic That’s Changing Lives: Addiction, Anxiety, Depression, Neurodegenerative Diseases & More
Summary
What if one psychedelic plant could change how we approach trauma, addiction, and even neurodegenerative diseases?
In this eye-opening episode of Keeping It Real, Jillian sits down with Bryan Hubbard, a leading voice in the psychedelic therapy space, to explore the power of Ibogaine therapy.
Together, they take a deep dive into:
How ibogaine works in the brain to disrupt addiction cycles, rewire trauma pathways, and stimulate neuroplasticity to help people with everything from sobriety to weight loss.
The powerful potential of ibogaine therapy to address depression, anxiety, PTSD, and stress-related illness
Why ibogaine may offer hope for those experiencing cognitive decline, and how it's being studied for conditions like Parkinson’s disease, multiple sclerosis (MS), and Lyme disease
The recent Stanford University–Ambio study, published in Nature Medicine, showing remarkable improvements in veterans with traumatic brain injuries — and no serious adverse events
Why veterans, trauma survivors, and chronic illness patients are turning to alternative, plant-based healing modalities
While ibogaine therapy remains unapproved by the FDA and is only legal in certain countries, this episode brings awareness to a growing global movement pushing the boundaries of how we understand and treat human suffering.
Disclaimer: This episode is for educational and informational purposes only. Ibogaine is not FDA-approved and should not be considered medical advice. Always consult with a qualified healthcare provider.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Episode details and artwork are published by the show’s own feed. Sentinel plays short cited excerpts and links every episode back to its publisher.




























